Estrogenic activity of isoflavonoids from Onobrychis ebenoides

Planta Medica

Volumn 72, Issue 6, 2006, Pages 488-493

  Halabalaki, Maria ^a   Alexi, Xanthippi ^b,c   Aligiannis, Nektarios ^a   Lambrinidis, George ^a   Pratsinis, Harris ^d   Florentin, Ida ^b   Mitakou, Sofia ^a   Mikros, Emmanuel ^a   Skaltsounis, Alexios Leandros ^a   Alexis, Michael N ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b INSTITUTE OF BIOLOGY   (Greece)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

Author keywords

Estrogenic activity; Isoflavones; Leguminosae; Onobrychis ebenoides

Indexed keywords

AFRORMOSIN; DAIDZEIN; EBENOSIN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FORMONONETIN; FULVESTRANT; GENISTEIN; ISOFLAVONOID; PLANT EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL PROLIFERATION; DRUG ACTIVITY; DRUG POTENCY; DRUG STRUCTURE; ENDOMETRIUM CANCER; GENE EXPRESSION; MEDICINAL PLANT; NONHUMAN; ONOBORYCHIS EBENOIDES;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGEN RECEPTOR ALPHA; FABACEAE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOFLAVONES; PHYTOESTROGENS; PHYTOTHERAPY; PLANT EXTRACTS; STRUCTURE-ACTIVITY RELATIONSHIP;

FABACEAE; ONOBRYCHIS EBENOIDES;

EID: 33744938204     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-916261     Document Type: Article

References (25)

1. Basly JP, Lavier MC. Dietary phytoestrogens: potential selective estrogen enzyme modulators? Planta Med 2005; 71: 287-94
2. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998; 139: 4252-63
3. Cos P, De Bruyne T, Apers S, Vanden Berghe D, Pieters L, Vlietinck AJ. Phytoestrogens: recent developments. Planta Med 2003; 69: 589-99
4. Beck V, Rohr U, Jungbauer A. Phytoestrogens derived from red clover: an alternative to estrogen replacement therapy? J Steroid Biochem Mol Biol 2005; 94: 499-518
5. Baber RJ, Templeman C, Morton T, Kelly GE, West L. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 1999; 2: 85-92.
6. Halabalaki M, Aligiannis N, Papoutsi Z, Mitakou S, Moutsatsou P, Sekeris C et al. Three new arylobenzofurans from Onobrychis ebenoides and evaluation of their binding affinity for the estrogen receptor. J Nat Prod 2000; 63: 1672-4
7. Papoutsi Z, Kassi E, Papaevangeliou D, Pratsinis H, Zoumpourlis V, Halabalaki M et al. Plant 2-arylobenzofurans demonstrate a selective estrogen receptor modulator profile. Steroids 2004; 69: 727-34.
8. Lu Y, Sun Y, Foo LY, McNabb WC, Molan AL. Phenolic glycosides of forage legume Onobrychis viciifolia. Phytochemistry 2000; 55: 67-75.
9. Jayaprakasam B, Damu AG, Rao KV, Gunasekar D, Blond A, Bodo B. 7-O-Methyltetrahydroochnaflavone, a new biflavanone from Ochna beddomei. J Nat Prod 2000; 63: 507-8
10. 13C labelled daidzein and formononetin. Bioorg Med Chem Lett 1998; 8: 2569-72
11. Fokialakis N, Lambrinidis G, Mitsiou DJ, Aligiannis N, Mitakou S, Skaltsounis AL et al. A new class of phytoestrogens; evaluation of the estrogenic activity of deoxybenzoins. Chem Biol 2004; 11: 397-406
12. Bhat KP, Pezzuto JM. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells. Cancer Res 2001; 61: 6137-44
13. Kinjo JK, Furusawa JI, Baba J, Takeshita T, Yamasaki M, Nohara T. Studies on the constituents of Pueraria lobata. III. Isoflavonoids and related compounds in the roots and the voluble stems. Chem Pharm Bull 1987; 35: 4846-50
14. Yin S, Fan CQ, Wang Y, Dong L, Yue JM. Antibacterial prenylflavone derivatives from Psoralea corylifolia and their structure-activity relationship study. Bioorg Med Chem 2004; 12: 4387-92
15. De Cremoux P, Tran-Perennou C, Brockdorff BL, Boudou E, Brunner N, Magdelenat H et al. Validation of real-time RT-PCR for analysis of human breast cancer cell lines resistant or sensitive to treatment with antiestrogens. Endocr Relat Cancer 2003; 10: 409-18
16. Lazennec G, Alcorn JL, Katzenellenbogen BS. Adenovirus-mediated delivery of a dominant negative estrogen receptor gene abrogates estrogen-stimulated gene expression and breast cancer cell proliferation. Mol Endocrinol 1999; 13: 969-80
17. Jang ER, Lim SJ, Lee ES, Jeong G, Kim TY, Bang YJ et al. The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen. Oncogene 2004; 23: 1724-36
18. Paine TM, Soule HD, Pauley RJ, Dawson PJ. Characterization of epithelial phenotypes in mortal and immortal human breast cells. Int J Cancer 1992; 50: 463-73
19. Pettersson K, Delaunay F, Gustafsson JA. Estrogen receptor beta acts as a dominant regulator of estrogen signaling. Oncogene 2000; 19: 4970-8
20. Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstrom O et al. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J 1999; 18: 4608-18
21. Ruh MF, Taylor JA, Howlett AC, Welshons WV. Failure of cannabinoid compounds to stimulate estrogen receptors. Biochem Pharmacol 1997; 53: 35-41
22. An J, Tzagarakis-Foster C, Scharschmidt TC, Lomri N, Leitman DC. Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens. J Biol Chem 2001; 276: 17808-14
23. Gangloff M, Ruff M, Eiler S, Duclaud S, Wurtz JM, Moras D. Crystal structure of a mutant hERalpha ligand-binding domain reveals key structural features for the mechanism of partial agonism. J Biol Chem 2001; 276: 15059-65
24. Kitaoka M, Kadokawa H, Sugano M, Ichikawa K, Taki M, Takaishi S et al. Prenylflavonoids: a new class of non-steroidal phytoestrogen (Part 1). Isolation of 8-isopentenylnaringenin and an initial study on its structure-activity relationship. Planta Med 1998; 64: 511-5
25. Zierau O, Gester S, Schwab P, Metz P, Kolba S, Wulf M et al. Estrogenic activity of the phytoestrogens naringenin, 6-(1,1-dimethylallyl)naringenin and 8-prenylnaringenin. Planta Med 2002; 68: 449-51